Prime Medicine

Prime Medicine is a biotechnology company developing gene editing therapies based on its Prime Editing platform. Prime editing is a versatile technology that can make targeted insertions, deletions, and all 12 types of base-to-base conversions in DNA without creating double-strand breaks. The company's mission is to create one-time, potentially curative genetic therapies. Its pipeline focuses on areas such as hematology, immunology (including Chronic Granulomatous Disease), liver diseases (Wilson's disease, AATD), and cystic fibrosis.